Here are five highlights:
1. The growth is attributed to the increasing number of geriatric patients as well as an increasing number of road accidents resulting in bone fractures.
2. Market players continue to focus on developing new devices. There has been a surge in osteoporosis devices.
3. The market will need to overcome product recalls, which have been more common in recent years. The increasing number of recalls is causing patients and surgeons to withdraw from using devices as part of their treatment procedures.
4. North America dominates the market and will continue to during the forecast period. The Middle East and Asia Pacific regions will see significant surges in the market due to larger reimbursements.
5. Key market players include Globus Medical, DePuy Synthes, Medtronic, Smith & Nephew and Arthrex.
More articles on devices and implants:
Stryker educates on joint health, sponsors service dog for veteran at golf championship: 3 insights
InVivo Therapeutics reports $3.2M net loss in Q3: 4 highlights
Alphatec reports $23M in Q3 revenue, up 3% — 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
